key: cord-1034820-gimc0ncn
authors: Birch, Cierra A.; Molinar-Inglis, Olivia; Trejo, JoAnn
title: Subcellular hot spots of GPCR signaling promote vascular inflammation
date: 2020-08-18
journal: Curr Opin Endocr Metab Res
DOI: 10.1016/j.coemr.2020.07.011
sha: 3cdd796716a278cfcd72063a717c6907b9302e45
doc_id: 1034820
cord_uid: gimc0ncn

G-coupled protein receptors (GPCRs) comprise the largest class of druggable targets. Signaling by GPCRs is initiated from subcellular hot spots including the plasma membrane, signalosomes and endosomes to contribute to vascular inflammation. GPCR-G protein signaling at the plasma membrane causes endothelial barrier disruption and also cross-talks with growth factor receptors to promote proinflammatory signaling. A second surge of GPCR signaling is initiated by cytoplasmic NFκB activation mediated by β-arrestins and CARMA-Bcl10-MALT1 signalosomes. Once internalized, ubiquitinated GPCRs initiate signaling from endosomes via assembly of the transforming growth factor-β-activated kinase binding protein-1 (TAB1)-TAB2-p38 MAPK complex to promote vascular inflammation. Understanding the complexities of GPCR signaling is critical for development of new strategies to treat vascular inflammation such as that associated with COVID-19.

Inflammation is a major component of the innate immune system that enables mammalian cells to respond to tissue damage and pathogens. Acute and chronic inflammation of the vasculature involves a multicellular response that culminates in immune cell recruitment, clearance of damaged cells, tissue repair, and endothelial cell activation [1] . Under normal conditions, endothelial cells form a semi-permeable barrier that restricts the movement of fluid and macromolecules into the interstitial space.

Endothelial cells also exert anti-inflammatory activities by inhibiting the recruitment and activation of leukocytes under basal conditions [2] . Endothelial activation in response to tissue damage and pathogens is governed by signaling cascades initiated by vasoactive factors, chemokines and cytokines, which are immune and endothelial cell-secreted inflammatory mediators that interact with cell surface receptors and trigger endothelial barrier permeability, gene transcription and apoptosis. Inflammatory mediators elicit cellular responses via activation of three major signaling pathways including: nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), Janus kinases (JAKs), signal transducer and activator of transcription (STAT), and the p38 mitogen-activated protein kinase (MAPK) signaling pathways [1] . While many inflammatory mediators signal through cytokine receptors, G protein-coupled receptors (GPCRs) also serve as important conduits for generating inflammatory signaling in endothelial cells and other cell types [3] .

GPCRs are a diverse family of cell surface transmembrane receptors that respond to various stimuli and promote an array of cellular functions. Upon agonist stimulation, GPCRs undergo conformational changes and facilitate activation of plasma membrane localized heterotrimeric G proteins that initiate intracellular signaling cascades. After activation, GPCRs are phosphorylated by GPCR kinases, bind the multi-functional adaptor β-arrestin proteins and internalize from the plasma membrane through clathrin-mediated endocytosis [4] . A second surge of signaling from activated GPCRs occurs within subcellular compartments and is enabled by β-arrestins, which function as scaffolds that nucleate the assembly of signaling complexes [5] . β-arrestin-2 has been shown to mediate pro-inflammatory responses via NFκB activation in the vascular endothelium [6] . An additional trigger of subcellular signaling is induced by J o u r n a l P r e -p r o o f ubiquitin covalently linked to activated GPCRs that regulates the recruitment and activation of p38 MAPK signaling complexes on endosomes [7, 8] . These studies demonstrate that not only plasma membrane-initiated GPCR signaling but also cytoplasmic-and endosomal-initiated signaling contributes to the orchestration of an effective inflammatory response. In this review, we summarize recent work indicating that in addition to promoting classical inflammatory signaling from the plasma membrane, some GPCRs can fine-tune vascular inflammatory responses by initiating a second surge of signaling from subcellular hot spots. A key temporal characteristic of pro-inflammatory GPCR agonists is the rapid activation of G q and G 12/13 protein signaling at the plasma membrane that disrupts endothelial cell-cell junctions resulting in transient permeability ( Figure 1 ). Thrombin, a procoagulant serine protease, signals primarily via protease-activated receptor-1 (PAR1), leading to G q -mediated Ca 2+ mobilization, protein kinase C activation and G 12/13 -dependent RhoA signaling to promote AJ disassembly and barrier disruption [10] .

Histamine acting through the H1 histamine receptor causes increases in intracellular Ca 2+ and c-Src activation [11] , whereas bradykinin activation of the bradykinin B2 receptor results in Ca 2+ mobilization and endothelial nitric oxide synthase activity [12] .

PAF signals via the PAF receptor, which couples to G q and Rac1 activation and J o u r n a l P r e -p r o o f promotes reorganization of the actin cytoskeleton and endothelial barrier disruption [13] .

Thus, the initiation of GPCR inflammatory signaling occrs at the plasma membrane via rapid coupling to heterotrimeric G proteins resulting in transient alteration of endothelial barrier permeability.

Of the key inflammatory pathways, activation of the JAK-STAT pathway is the most proximal to the plasma membrane with a simple architecture that permits direct communication with the nucleus. A wide array of cytokine and growth factor receptors directly activate JAK-STAT pathways, whereas GPCRs appear to signal indirectly to the JAK-STAT pathway via crosstalk with other receptors in the vascular endothelium ( Figure 1 ). Additionally, JAK interacts directly with the GPCR angiotensin II type 1 receptor (AT1 receptor) and PAF receptor in smooth muscle and other cell types [14] .

Classically, JAK proteins associate with the cytoplasmic tail of ligand-bound cytokine and growth factor receptors to trigger phosphorylation of STAT family transcription factors, resulting in dimerization, subsequent nuclear translocation and STATdependent gene expression that promotes apoptosis, cell migration, and differentiation [15] . However, bradykinin activation of B2 receptor stimulates extracellular signal regulated kinases-1/2-mediated STAT activation that bridges a positive regulatory loop with the fibroblast-growth-factor (FGF-2)-FGR1 axis to stimulate endothelial cell barrier disruption and migration [16] . Interestingly, new work suggests that complement factors promote vascular inflammation via GPCR signaling. Activation of the complement pathway during vascular injury results in the release of complement activated peptides C3a and C5a, which signal through the anaphylatoxin C3a and C5a GPCRs expressed in endothelial cells. In recent work, C3a and C5a stimulated endothelial cells exhibited enhanced C3a and C5a receptor expression and a host of pro-inflammatory responses including lymphocyte activation, infiltration and cytokine production that was diminished by a JAK inhibitor [17] , implicating a role for the JAK-STAT inflammatory signaling pathway. Although these GPCRs appear to initiate JAK-STAT activation from the cell surface, other receptors may require endocytosis for coupling to this inflammatory pathway. CARMA associates with two signaling proteins B-cell lymphoma protein 10 (Bcl10) and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) termed the CBM complex ( Figure 2 ). Activation of CBM is initiated by PKC-dependent phosphorylation of CARMA [21] , which nucleates complex formation with the constitutively associated Bcl10 and MALT1 proteins and contributes to the regulation of the inhibitor of NFκB kinase (IKK) complex activity through polyubiquitination [22] .

Interestingly, CBM complexes can mature into higher-order oligomers that generate "hubs" of signalosomes for localized and sustained enhancement of NFκB activity in the cytoplasm [23] . Moreover, thrombin-induced CBM complex formation requires β-arrestin-2, suggestion that β-arrestin-2 may function as a scaffold to facilitate nucleation of the CBM complex.

Thrombin activation of the CBM complex also results in an additional MALT1-dependent response resulting in proteolytic degradation of the microtubule stabilizing protein cylindromatosis that triggers endothelial cell retraction and acute barrier permeability ( Figure 2 ) [27] . Consistent with these findings, a recent study demonstrated that histamine acting via the H1 histamine receptor increases MALT1 activity and is required for histamine-induced endothelial barrier permeability in vitro and in vivo [28] . Together, these studies suggest that endothelial GPCRs utilize CBM for dual inflammatory functions including NFκB activation and endothelial barrier disruption.

The p38 MAPK signaling cascade is a key mediator of inflammation [29] and known to regulate stress-and inflammation-induced cellular and transcriptional responses in various cell types [30, 31] . New emerging data suggest that like CBM, p38 MAPK has dual inflammatory functions controlling both gene transcription and cellular responses such as endothelial barrier permeability. All four p38 isoforms (α, β, δ and γ) are activated by the canonical 3-tiered kinase cascade mediated by upstream MAP2Ks and MAP3Ks [32, 33] . However, a non-canonical pathway of p38 MAPK activation is prevalent and utilized by cytokines and GPCR agonists via transforming growth factorβ-activated kinase binding protein-1 (TAB1). TAB1 directly binds the p38α isoform resulting in autophosphorylation and activation that bypasses the requirement for upstream MAPK2s and MAP3Ks ( Figure 2) ubiquitin ligase and initiated at the cell surface by G protein signaling, however activated ubiquitinated PAR1-TAB1-TAB2 complex accumulates on endosomes and propagates prolonged p38 MAPK activity in the cytoplasm [7] . Ubiquitin-driven p38 MAPK signaling induced by PAR1 promotes endothelial barrier permeability in vitro and p38 MAPK is required for PAR1-stimulated vascular leakage in vivo [7] . ADP stimulation of the P2Y1 receptor also requires ubiquitination, TAB1 and TAB2 to activate endosomal p38 MAPK signaling, indicating that this pathway is not limited to PAR1. In fact, multiple endothelial GPCRs agonists including histamine and prostaglandins also require TAB1 as well as TAB2 or TAB3 to stimulate p38 MAPK-dependent induction of interleukin-6 production in various types of endothelial cells derived from different vascular beds [36] , suggesting that TAB1-dependent p38 MAPK activation is a universal pathway utilized by GPCRs.

A critical role for ubiquitin as a trigger for GPCR-induced p38 MAPK inflammatory signaling is further supported by recent work that has unveiled the mechanism of NEDD4 E3 ligase activation induced by GPCRs. In this work, activated PAR1 was shown to stimulate NEDD4 E3 ligase activity through c-Src-dependent phosphorylation of a tyrosine residue within the 2,3-linker peptide of WW2 and WW3 of NEDD4 to promote p38 MAPK signaling and endothelial barrier disruption [8] . C-Src was also shown to function as a key regulator of NEDD4 activity and ubiquitin-driven p38 MAPK inflammatory signaling induced by activated P2Y1.

Interestingly, both p38 MAPK and GPCRs have been implicated in the progression of the coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which leads to massive inflammation in the lung and heart. The exact cause of inflammation is not known.

SAR2-CoV-2 binds to angiotensin converting enzyme-2 (ACE2) expressed on cells highly abundant in the lung and heart. ACE-2 is important for controlling the levels of angiotensin II, which signals through AT1 to promote inflammatory signaling including p38 MAPK activation [37] . In addition, a human-SARS-CoV-2-host interactome screen revealed that PAR2 associates with SARS-CoV-2 via an accessory protein in the region

Ofr9c [38] . PAR2 also plays a pivotal role in vascular inflammation [39] and can signal J o u r n a l P r e -p r o o f via p38 MAPK [40] . Given the lack of clinically efficacious drugs currently available to treat COVID-19, small molecule inhibitors targeting certain GPCRs and/or p38 MAPK might be considered for early phase clinical trials. 

Inflammatory responses and inflammation-associated diseases in organs

Inflammation and the blood microvascular system

Role of G protein-coupled receptors in inflammation

GPCR Signaling Regulation: The Role of GRKs and Arrestins

Advances in Membrane Trafficking and Endosomal Signaling of G Protein-Coupled Receptors

Regulation of inflammation by beta-arrestins: Not just receptor tales

Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes

This study shows that GPCRs stimulate activation of the NEDD4-2 E3 ubiquitin ligase via c-Src to induce endothelial p38 proinflammatory signaling. c-Src phosphorylates NEDD4-2 at tyrosine-485, releasing the autoinhibitory linker peptide that is critical for enhancing E3 ligase activity, and provides mechanistic insight of how GPCRs activate E3 ubiquitin ligases in mammalian cells

Endothelial Cell Calcium Signaling during Barrier Function and Inflammation

Dual regulation of endothelial junctional permeability

VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability

Bradykinin specificity and signaling at GPR100 and B2 kinin receptors

Tiam1 and Rac1 are required for platelet-activating factorinduced endothelial junctional disassembly and increase in vascular permeability

Fine-tuning of GPCR activity by receptor-interacting proteins

The molecular details of cytokine signaling via the JAK/STAT pathway

Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1

In response to complement anaphylatoxin peptides C3a * and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells

NF-kappaB signaling in inflammation

beta-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders

CARMA3: Scaffold Protein Involved in NF-kappaB Signaling. Front Immunol

Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling

Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6

Using biophysical approaches this work studied the assembly of the CARMA1-BCL10-MALT1-TRAF6 complex and showed that CARMA1 nucleates BCL10 filament formation resulting in MALT1 dimerization and activation

CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex

Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3.Bcl10.MALT1 signalosome

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells

MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage

MALT1 Protease Plays a Dual Role in the Allergic Response * by Acting in Both Mast Cells and Endothelial Cells

This study showed that in addition to mediating allergic responses in mast cells, MALT1 has a pivotal role in promoting endothelial inflammatory responses induced by histamine, a mast cell vasoactive substance

Roles of p38alpha mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer

The p38 Pathway: From Biology to Cancer Therapy

Mechanisms and functions of p38 MAPK signalling

Differential activation of p38MAPK isoforms by MKK6 and MKK3

Mechanism of p38 MAP kinase activation in vivo

MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha

The TAB1-p38alpha complex aggravates myocardial injury and can be targeted by small molecules

G protein-coupled receptors activate p38 MAPK via a non canonical TAB1-TAB2-and TAB1-TAB3-dependent pathway in endothelial cells

p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension

This study identified several potential druggable targets by generating a human-SARS-CoV-2 protein interaction map that includes the GPCR PAR2

Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice

The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion

We thank members of the Trejo laboratory of suggestions and advice. 

Angiotensin converting enzyme-2, ACE2; adherens junctions, AJ; angiotensin II type 1